Aussies you'll meet at BIO

Australia is home to a thriving and dynamic biotechnology industry with a firm footing in the world-class research base found in the universities and research institutions 'Down Under'.

Within Australia's biotechnology sector are numerous companies developing innovative new devices, drugs and therapeutics for a variety of human diseases, agricultural and veterinary biotechnology companies, and a burgeoning field of companies and contract research organisations (CROs) providing regulatory advice, clinical trials expertise, development of animal models and contract development and manufacturing services for local and international companies.

Australian exhibitors at BIO2004 span the gamut, from emerging drug development companies like Alzhyme and Phylogica, to experienced players in the sector like Biota, GroPep and Proteome Systems.

Australia's major research institutions -- housing the inventors of many innovative Australian biotechnology products -- are also making a strong showing at the conference, with new opportunities aplenty.

A variety of contract research organisations (CROs) with plenty of experience in running clinical trials in Australia and elsewhere will also be on hand to show the world why Australia has a well-deserved role to play in clinical trials.

And Australia's state and federal governments are showing their support for the industry and recognition of its importance to the future economy of the nation, by turning out for the conference.

Drug delivery and Medical Devices

Acrux Igor Gonda, CEO Tel: +61 3 8379 0110 igor.gonda@acrux.com.au www.acrux.com.au Acrux MDTS and ACROSS technology for transdermal drug delivery

Biomedtech Australia Oleg Bassovitch, CEO Tel: +61 3 9553 7200 info@go2altitude.com www.go2altitude.com Development of hypoxicators for the delivery of Intermittent Hypoxic Treatment (IHT)

Equipment manufacturers and developers

Corbett Research John Corbett Tel: +61 2 9736 1320 john@corbettresearch.com wwwcorbettresearch.com Manufacturer of robotics and real time amplification systems

Invetech Ian Macfarlane Tel: +1 415 693 0141 rmb@invetech.com.au www.invetech.com.au Instrument design and manufacture for clinical diagnostics, life science and biotechnology

MiniFAB (Australia) Michael Wilkinson, COO Tel: +61 3 9764 2241 michaelwilkinson@minifab.com.au www.minifab.com.au Design, prototyping and manufacture of biochips, devices and sensors based on unique set of capabilities in microfluidics and microfabrication of polymers and plastics

Proteome Systems Bob Bondaryk, VP Marketing North America Tel: +61 2 9889 1830 angela.grima@proteomesystems.com www.proteomesystems.com Development of proteomics technology, the discovery of biomarkers and drug targets, and proteomic bioinformatics

Biotechnology companies

Alchemia Kris Dyszynski, VP Business Development Tel: +61 7 3340 0200 k.dyszynski@alchemia.com.au www.alchemia.com Drug discovery technology, therapeutic drug candidates, and carbohydrate custom manufacturing services

Alzhyme Marcus Christian, CEO Tel: +61 8 9480 1184 mchristian@alzhyme.com www.alzhyme.com Drug development for Alzheimer's disease

Biota Holdings Peter Molloy, CEO Tel: +61 3 9529 2311 c.simmonds@biota.com.au www.biota.com.au Antiviral drug discovery technologies and programs

Biotron Dr Michelle Miller, CEO Tel: +61 2 6125 8001 mmiller@biotron.com.au www.biotron.com.au Virion, a novel class of anti-HIV therapeutics; C-Test, novel tests for early diagnosis of cancer using mass spectrometry

BresaGen Dr Meera Verma, VP and COO Tel: +61 8 8234 2660 mverma@bresagen.com.au www.bresagen.com Recombinant protein and peptide production and contract process development

CollTech Michael Pixley Tel: +61 8 9388 7600 mpixley@colltech.com.au www.colltech.com.au Extraction of highly purified collagen from sheep skins for medical and biopharmaceutical markets

CyGenics Ian Brown, COO Tel: +61 3 8344 9720 ian.brown@cygenics.com wwwcygenics.com Development and commercialisation of stem cell related products, services, applications and technologies

EvoGenix Dr Merilyn Sleigh, CEO Tel: +61 2 8257 3393 m.sleigh@evogenix.com.au www.evogenix.com EvoGene technology for selection of improved protein therapeutics

GroPep Robert Finder, MD and CEO +61 8 8354 7700 sarah.mortellaro@gropep.com.au www.gropep.com.au Biopharmaceutical drug development and commercialisation of human health products

Metabolic Pharmaceuticals Dr Chris Belyea, CEO Tel: +61 3 9860 5700 chris.belyea@metabolic.com.au www.metabolic.com.au Drug development for obesity, pain, type 2 diabetes and bone disorders

Phylogica Rolee Kumar, operations manager Tel: +61 8 9489 7910 roleek@phylogica.com www.phylogica.com Proteomics-based drug discovery focused on identifying and blocking specific protein interactions

Progen Industries Dr Darren M Schliebs Tel: +61 7 3273 9191 darren.schliebs@progen.com.au www.progen.com.au Discovery and development of oncology therapeutics

pSivida Dr Roger Aston Tel: +61 8 9226 5099 joshuamann@psivida.com.au www.psivida.com.au Development of nano-structured porous silicon for drug delivery and diagnostics

Rockeby Biomed Dr Sze Wee Tan, CEO Tel: +61 8 9470 9444 john.warmington@rockeby.com www.rockeby.com Development of products for diagnosis and treatment of human fungal infections

Solbec Pharmaceuticals Stephen Carter, CEO Tel: +61 8 9446 7555 stephen.carter@solbec.com.au www.solbec.com.au Development and commercialisation of glycoalkaloid-based therapies for cancer and psoriasis

Tatura-Anadis Tony McKenna Tel: +61 3 5824 6200 tmckenna@tatmilk.com.au www.tatmilk.com.au www.anadis.com.au Tatura Milk Industries and Anadis are developing nutraceutical and complementary medical products based on colostrum from vaccinated cows

Vaccine Solutions Beryl Morris, CEO Tel: +61 7 3362 0220 beryl.morris@vaccine-solutions.com.au www.vaccine-solutions.com.au Human and animal vaccine technologies

Service Organisations and CROs

AusBiotech Paris Brooke, Policy and Communications Manager Tel: +61 3 9208 4318 pbrooke@ausbiotech.org www.ausbiotech.org Australia's biotechnology industry organisation

Australian Proteome Analysis Facility Lindsay Woods, Director of Business Development Tel: +61 2 9850 6201 lwoods@proteome.org.au www.proteome.org.au Proteomic technology. APAF is dedicated to working together with international, national and local pharmaceutical, biotechnology, agricultural and academic bodies with the aim of using new technologies to aid in the discovery of therapeutic, diagnostic and quality markers for these industries.

Clinical Network Services (CNS) Prof Tony Webber, CEO Tel: +61 7 3378 3577 tony.webber@clinetserv.com www.clinetserv.com Contract research organisation servicing international healthcare community

Clinical Trials Victoria Prof Anthony Rebuck, CEO Tel: +61 417 501 209 tony.rebuck@baker.edu.au www.clinicaltrialsvictoria.com Clinical research expertise and clinical trials services from Phase I to Phase IV for biotechnology and pharmaceutical organisations

Datapharm John Edington Tel: +61 2 9719 2800 info@datapharm.com.au www.datapharm.com.au Full service contract research organisation and data management organisation

Novotech (Australia) Julia Jones, Associate Director Business Development Tel: +61 2 9518 9600 julia.jones@novotech-cro.com www.novotech-cro.com Full service clinical contract research organisation

Ozgene Eddie Noonan, business development manager Tel: +61 8 9212 2200 enoonan@ozgene.com www.ozgene.com GM mouse/rat services

Phillips Ormonde & Fitzpatrick Debra Fin Yoo Tel: +61 3 9614 1944 ann.kurts@pof.com.au www.pof.com.au Intellectual property services to biotechnology and other industries

Q-Pharm Prof Wayne Hooper, managing director Tel: +61 7 3845 3636 t.hurst@qpharm.com.au www.qpharm.com.au Contract research organisation specialising in Phase I clinical trials for the pharmaceutical and biotechnology industries

Research institutes and universities

Australian National Stem Cell Centre Dianna DeVore, COO Tel: +61 3 9542 7100 dianna.devore@nscc.edu.au www.nscc.edu.au Biotechnology Centre of Excellence in stem cell biology, tissue matrices and transplantation immunology

Australian Plant DNA Bank Prof Robert Henry Tel: +61 2 6620 3466 rhenry@scu.edu.au www.dnabank.com.au Plant biobanking services, genetic technologies for discovery of plant bioactive products

BIO21 Institute Prof Dick Wettenhall, Director Tel: +61 3 8344 5914 rehw@unimelb.edu.au www.bio21.org Commercial medical, veterinary, agriculture and environmental biotech programs based in the BIO 21 cluster, incorporating the University of Melbourne, the Walter and Eliza Hall Institute, Royal Melbourne Hospital and Neurosciences Victoria

Cellulose Valley Institute Prof Peter Baverstock Tel: +61 2 6626 9440 jsummers@scu.edu.au www.cellulosevalley.com.au Plant research collective providing research facilities, services and expertise in plant genetics, phytochemistry, health services, pharmacognostics, environmental and resource science

CSIRO Dr Mikael Hirsch, biotechnology coordinator Tel: +61 2 6246 4452 mikael.hirsch@csiro.au www.csiro.au Australia's national research organisation

Garvan Institute of Medical Research and Biolink Dr Jonathan Izant, director of business development Tel: +61 2 9295 8130 j.izant@garvan.org.au www.garvan.org.au Superior biomedical technology from Garvan and Bio-link

Monash University and Monash Institutes of Health Jonathan Sanders Tel: +61 3 9905 9731 kylie.thoroughgood@med.monash.edu.au www.monash.edu.au www.monashinstitutes.org Biotechnology capabilities that deliver a seamless move from research through to clinical trials and commercialisation

Queensland University of Technology Prof James Dale Tel: +61 7 3864 2819 j.dale@qut.edu.au www.qut.edu.au Technologies from the Queensland University of Technology

SARDI: South Australian Research & Development Institute Dr Rob Lewis, executive director Tel: +61 8 8303 9397 lewis.rob@saugov.sa.gov.au www.sardi.sa.gov.au Research and development institute delivering innovation to enhance the food, fibre and bioscience industries and living environmental systems

University of Adelaide Janet Dibb-Smith Tel: +61 8 8303 6253 elaine.stead@adelaide.edu.au www.adelaide.edu.au/ari Intellectual property, research capacity

University of Sydney, Business Liaison Office Michael Prodigalidad, Business Development Manager Tel: +61 2 9036 9640 m.prodigalidad@blo.usyd.edu.au www.usyd.edu.au/blo Technologies from the University of Sydney

UniQuest David Henderson, managing director Tel: +61 7 3365 4037 j.renaud@uniquest.com.au www.uniquest.com.au Commercialisation and tech transfer for technologies developed at the University of Queensland

Government Agencies

Australian Trade Commission (Austrade) Olivia Jenq Tel: +1 415 243 2069 olivia.jenq@austrade.gov.au www.austrade.gov.au Australian Federal Government agency that helps Australian companies win overseas business for their products and services

Bio Innovation SA Dr Jurgen Michaelis, CEO Tel: +61 8 8217 6415 info@bioinnovationsa.com.au www.bioinnovationsa.com.au Promotion and support for the South Australian bioscience industry

BusinessACT Glen Hassett Tel: +61 2 6205 0549 glen.hassett@act.gov.au www.business.act.gov.au Business development arm of Australian Capital Territory Government

Government of Victoria Trish Vardon, Tel: +61 3 9651 9276 trish.varden@iird.vic.gov.au www.biotechnology.vic.gov.au Promotion of the Victorian biotechnology industry

Government of Western Australia Colin Slattery, senior project manager Tel: +61 8 9222 5580 colin.slattery@doir.wa.gov.au www.doir.wa.gov.au The Department of Industry and Resources (DOIR) advances the responsible development of industry and resources for the benefit of Western Australian companies

Invest Australia Robert Hunt Tel: +1 415 243 2076 robert.hunt@investaustralia.gov.au www.investaustralia.gov.au/biotech Promoting biotechnology investment in Australia

NSW Department of State and Regional Development Shane Coombe Tel: +61 2 9338 6968 shane.coombe@business.nsw.gov.au www.business.nsw.gov.au/biotech Promotion of the NSW biotechnology industry

Queensland Government Ross Brodie, manager biotechnology, department of state development and innovation Tel: +61 7 3227 8617 ross.brodie@iie.qld.gov.au www.sd.qld.gov.au/innovation Queensland's capabilities, key competitive advantages and strengths